胶质母细胞瘤患者切除程度与残余肿瘤体积的自动评估
本研究回顾性分析19例经组织学确诊的幕上胶质母细胞瘤初次切除术患者的影像数据,由4名评估者与全自动分割软件BraTumIA分别分割术前及术后即刻MRI上的对比增强肿瘤,并定量比较两者结果。BraTumIA对切除程度与残余肿瘤体积的估计与人类专家相近,但倾向于高估对比增强肿瘤体积,与专家评估仅呈中等一致性。
要点
- BraTumIA可全自动给出与人类专家相近的切除程度和残余肿瘤体积估计。
- 4名评估者间残余肿瘤体积的一致性系数W=0.812(p<0.001),高于切除程度的W=0.775(p<0.001)。
- BraTumIA与人类评估者之间未检出统计学显著差异,但其倾向高估对比增强肿瘤体积。
核心结论
- BraTumIA能以全自动方式生成与人类专家估计相近的切除程度和残余肿瘤体积,但自动分析倾向于高估对比增强肿瘤体积,而人工分析易受主观性影响,导致评估者间存在相当大的变异性。
研究设计与样本
- 回顾性分析19例经组织学确诊的幕上胶质母细胞瘤初次切除术患者的影像数据,由4名评估者与全自动分割软件BraTumIA分别分割术前及术后即刻MRI上的对比增强肿瘤,并做定量比较。
主要发现
- 评估者间残余肿瘤体积的一致性系数W=0.812(p<0.001),高于切除程度的W=0.775(p<0.001)。
- BraTumIA与人类评估者比较,切除程度W=0.713(p<0.001)、残余肿瘤体积W=0.693(p<0.001),其估计值总体接近或位于人类评估者估计值之间。
- 人工与自动估计之间未检出统计学显著差异。
- BraTumIA倾向于高估对比增强肿瘤,在文献报道的、与生存相关的切除程度阈值上,与专家评估者仅呈中等一致性。
关键数值与推荐
- 残余肿瘤体积的评估者间一致性系数W=0.812(p<0.001),切除程度的评估者间一致性系数W=0.775(p<0.001)。
- BraTumIA与人类评估者比较,切除程度W=0.713(p<0.001),残余肿瘤体积W=0.693(p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文为回顾性研究,纳入19例患者。
- 自动分析倾向于高估对比增强肿瘤体积,人工分析易受主观性影响并导致相当大的评估者间变异性。
- 自动分析与专家评估在文献报道的、与生存相关的切除程度阈值上仅呈中等一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE In the treatment of glioblastoma, residual tumor burden is the only prognostic factor that can be actively influenced by therapy. Therefore, an accurate, reproducible, and objective measurement of residual tumor burden is necessary. This study aimed to evaluate the use of a fully automatic segmentation method-brain tumor image analysis (BraTumIA)-for estimating the extent of resection (EOR) and residual tumor volume (RTV) of contrast-enhancing tumor after surgery. METHODS The imaging data of 19 patients who underwent primary resection of histologically confirmed supratentorial glioblastoma were retrospectively reviewed. Contrast-enhancing tumors apparent on structural preoperative and immediate postoperative MR imaging in this patient cohort were segmented by 4 different raters and the automatic segmentation BraTumIA software. The manual and automatic results were quantitatively compared. RESULTS First, the interrater variabilities in the estimates of EOR and RTV were assessed for all human raters. Interrater agreement in terms of the coefficient of concordance (W) was higher for RTV (W = 0.812; p < 0.001) than for EOR (W = 0.775; p < 0.001). Second, the volumetric estimates of BraTumIA for all 19 patients were compared with the estimates of the human raters, which showed that for both EOR (W = 0.713; p < 0.001) and RTV (W = 0.693; p < 0.001) the estimates of BraTumIA were generally located close to or between the estimates of the human raters. No statistically significant differences were detected between the manual and automatic estimates. BraTumIA showed a tendency to overestimate contrast-enhancing tumors, leading to moderate agreement with expert raters with respect to the literature-based, survival-relevant threshold values for EOR. CONCLUSIONS BraTumIA can generate volumetric estimates of EOR and RTV, in a fully automatic fashion, which are comparable to the estimates of human experts. However, automated analysis showed a tendency to overestimate the volume of a contrast-enhancing tumor, whereas manual analysis is prone to subjectivity, thereby causing considerable interrater variability.
引用
- Meier R, Porz N, Knecht U, et al. Automatic estimation of extent of resection and residual tumor volume of patients with glioblastoma. J Neurosurg. 2017. PMID: 28059651. doi:10.3171/2016.9.JNS16146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。